Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study (Q39123683)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 7 December 2016

Language	Label	Description	Also known as
English	Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study	scientific article published on 7 December 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study (English)

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

1 reference

based on heuristic

inferred from title

serous carcinoma

1 reference

based on heuristic

inferred from title

Uterine serous carcinoma

1 reference

based on heuristic

inferred from title

object named as

Cara A Mathews

18

0 references

Angeles Alvarez Secord

20

object named as

Angeles Alvarez Secord

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

12

object named as

Kay Park

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

author name string

Abigail D Winder

1

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Kruti P Maniar

2

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Jian-Jun Wei

3

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Dachao Liu

4

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Denise M Scholtens

5

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

John R Lurain

6

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Julian C Schink

7

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Barbara M Buttin

8

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Virginia L Filiaci

9

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Heather A Lankes

10

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Nilsa C Ramirez

11

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Meenakshi Singh

13

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Richard W Lieberman

14

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Robert S Mannel

15

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Matthew A Powell

16

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Floor J Backes

17

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Michael L Pearl

19

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

David J Peace

21

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

David G Mutch

22

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

William T Creasman

23

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

J Julie Kim

24

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

language of work or name

0 references

publication date

7 December 2016

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

123

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

7

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

1144-1155

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Cancer statistics, 2015

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Unconventional secretion of synuclein-γ promotes tumor cell invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

HER2 immunohistochemistry significantly overestimates HER2 amplification in uterine papillary serous carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

AKT involvement in cisplatin chemoresistance of human uterine cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Overexpression of synuclein-gamma in pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

10 July 2018

Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

The correlation between expression of synuclein-gamma, glucose transporter-1, and survival outcomes in endometrioid endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Serous carcinoma of the uterus-determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Commenting on "HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed? (88:263-5) by Santin AD".

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Stage-specific expression of breast cancer-specific gene gamma-synuclein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Stimulation of estrogen receptor signaling by gamma synuclein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5360512

21 August 2018

Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30477

7 January 2021

based on heuristic

inferred from DOI database lookup

Pure compared with mixed serous endometrial carcinoma: two different entities?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30477

7 January 2021

based on heuristic

inferred from DOI database lookup

Minor serous and clear cell components adversely affect prognosis in ''mixed-type'' endometrial carcinomas: a clinicopathologic study of 36 stage-I cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30477

7 January 2021

based on heuristic

inferred from DOI database lookup

Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30477

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27926776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.30477

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

release_rsak2nt23jdxlmxyff3aduualy

1 reference

https://api.fatcat.wiki/v0/release/rsak2nt23jdxlmxyff3aduualy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 July 2018

http://europepmc.org/abstract/PMC/5360512

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39123683&oldid=2264494533"